---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-022843"
form_type: "8-K"
ticker: "GNPX"
cik: "0001595248"
company_name: "Genprex, Inc."
filed_at: "2021-09-29T23:59:59+00:00"
generated_at: "2026-06-29T00:42:15.176385+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Genprex appoints Dr. Mark Berger as CMO, Dr. Hemant Kumar as CTO; COO Redman's role reduced

## Summary
- Mark Berger, MD appointed Chief Medical Officer; Hemant Kumar, PhD appointed Chief Manufacturing and Technology Officer.
- Michael Redman, EVP and COO, no longer oversees clinical and manufacturing operations; company in discussions for alternate role.
- Appointments effective September 2021 as disclosed in prior 8-K filed September 28, 2021.

## SEC filing metadata
- accession: 0001437749-21-022843
- form_type: 8-K
- ticker: GNPX
- cik: 0001595248
- company_name: Genprex, Inc.
- filed_at: 2021-09-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595248/000143774921022843/0001437749-21-022843-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595248/000143774921022843/gnpx20210929_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-022843
- JSON: https://secwatch.observer/filing/0001437749-21-022843.json
- Plain text: https://secwatch.observer/filing/0001437749-21-022843.txt

## Key facts
- Executive change
  Michael Redman changed role as Executive Vice President and Chief Operating Officer at Genprex, Inc..
  - Action: reassigned
  - Role: Executive Vice President and Chief Operating Officer
  source text: With these new appointments, Michael Redman, the Company’s Executive Vice President and Chief Operating Officer is no longer overseeing the Company’s clinical and manufacturing operations.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1595248/000143774921022843/0001437749-21-022843-index.htm
- Executive change
  Hemant Kumar was appointed as Chief Manufacturing and Technology Officer at Genprex, Inc..
  - Action: appointed
  - Role: Chief Manufacturing and Technology Officer
  source text: the Company has appointed Mark Berger, MD and Hemant Kumar, PhD as its new Chief Medical Officer and new Chief Manufacturing and Technology Officer, respectively.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1595248/000143774921022843/0001437749-21-022843-index.htm
- Executive change
  Mark Berger was appointed as Chief Medical Officer at Genprex, Inc..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: the Company has appointed Mark Berger, MD and Hemant Kumar, PhD as its new Chief Medical Officer and new Chief Manufacturing and Technology Officer, respectively.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1595248/000143774921022843/0001437749-21-022843-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.